Pfizer’s RSV vaccine shows benefit in immuno-compromised adults in study
In a late-stage study, Pfizer’s Abrysvo vaccine generated robust antibodies against RSV-A and RSV-B in immunocompromised adults,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
RSV vaccine
US FDA expands approval to GSK’s Arexvy for adults aged 50-59, at increased risk
The RSV vaccine adjuvanted is currently approved for use in adults aged 60 and older and recommended by CDC/ACIP using shared…
Moderna receives U.S. FDA approval for RSV vaccine mRESVIA(R)
mRESVIA is Moderna's second approved product and reportedly the only RSV vaccine available in single-dose pre-filled syringes …
US FDA approves GSK’s Arexvy, world’s first RSV vaccine for older adults
Older adults, including those with underlying medical conditions such as diabetes and chronic heart and lung disease, are at…
Moderna says RSV vaccine 84 per cent effective at preventing symptoms in older adults
There is currently no vaccine for the virus in adults. Moderna, Pfizer and GSK are racing to get their RSV vaccines to market…
GSK says key trial data shows its RSV vaccine is ‘truly exceptional’
The trial, which involved roughly 25,000 adults aged 60 years and more, tested a single dose of the experimental vaccine against a…